NRI Current Affairs - 2020
The All India Football Federation recently recommended the former Indian Captain IM Vijayan for the fourth highest civilian award in India, the Padmashri.
IM Vijayan has scored 40 goals in over 79 matches. He won the Arjuna award in 2003. Also, in 1993, 1997 and in 1999 he was awarded the best Indian “Player of the year”.
PAdmashri is the fourth highest civilian award in India. The other three highest civilian awards include Bharat Ratna, PAdma Vibhushan and Padma Bhushan. The awards are presented by the President of India during Republic Day celebrations of the country.
The Padma Awards are being awarded to the citizens since 1954. The awards are being presented under the categories such as medicine, education, sports, literature, industry, public affairs, social service.
As of 2020, around 3,123 people have received the award.
Tags: AIFF • AIFF Awards • AIFF Player of Year • All India Football Federation • COVID-19
The doctors of Indian origin spread all over the world have come together under an initiative called “Global Indian Physician COVID-19”. The initiative aims to foster cross system learning.
The initiative will work on early warning algorithm, vaccination, antiviral therapy and plasma therapy of COVID-19. Several leading associations of doctors all over the world namely Global Association of Physicians of Indian Origin, British Association of Physicians of Indian Origin, American Association of Physicians of Indian Origin and Canadian Association of Physicians of Indian Heritage are a part of the collaboration.
The collaboration is to meet through video conferencing.
The initiative will help doctors learn about successful drugs being used by doctors spread all over the world. The pros and cons of using drugs that have been recommended so far such as remdesivir, lopinavir, gilead, hydroxychloroquine, etc will be shared.
The drugs to treat the virus are still on clinical trials. Therefore, the association apart from safety and effectivity of the drugs, will also help learn about its activity on different patients.